- ISIN
- US4364401012
- CUSIP
- 436440101
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- IPO Date
- Jun 21, 1990
Highlights
- Market Cap
- $17.17B
- Enterprise Value
- $15.03B
- EPS (TTM)
- $2.41
- PE Ratio
- 31.54
- Total Revenue (TTM)
- $4.13B
- Gross Profit (TTM)
- $2.18B
- EBITDA (TTM)
- $1.01B
- Year Range
- $63.19 - $76.07
- Target Price
- $77.80
- ROA (TTM)
- 5.92%
- ROE (TTM)
- 10.37%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
HOLX Performance Chart
Loading charts...
Returns By Period
Hologic, Inc.
- 1D
- —
- 1M
- —
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.74%
- 1M
- 4.90%
- YTD
- 10.35%
- 6M
- 10.28%
- 1Y
- 26.52%
- 3Y*
- 20.83%
- 5Y*
- 12.30%
- 10Y*
- 13.66%
HOLX Monthly Returns History
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.59% | 0.57% | 0.31% | 0.56% | 2.04% | ||||||||
| 2025 | 0.07% | -12.13% | -2.56% | -5.78% | 6.82% | 4.81% | 2.55% | 0.45% | 0.55% | 9.51% | 1.43% | -0.64% | 3.33% |
| 2024 | 4.18% | -0.86% | 5.64% | -2.81% | -2.63% | 0.64% | 9.91% | -0.45% | 0.27% | -0.72% | -1.69% | -9.32% | 0.90% |
| 2023 | 8.77% | -2.13% | 1.33% | 6.58% | -8.28% | 2.64% | -1.91% | -5.89% | -7.14% | -4.65% | 7.75% | 0.21% | -4.49% |
| 2022 | -8.25% | 1.32% | 7.94% | -6.29% | 4.56% | -7.93% | 3.00% | -5.35% | -4.50% | 5.08% | 12.33% | -1.77% | -2.29% |
| 2021 | 9.47% | -9.58% | 3.18% | -11.87% | -3.80% | 5.80% | 12.47% | 5.48% | -6.75% | -0.68% | 1.94% | 2.45% | 5.12% |
Benchmark Metrics
Hologic, Inc. has an annualized alpha of 14.78%, beta of 0.88, and R2 of 0.09 versus S&P 500 Index. Calculated based on daily prices since June 22, 1990.
- This stock captured 124.28% of S&P 500 Index gains and 117.52% of its losses - amplifying both gains and losses, but participating more in upside than downside.
- R2 of 0.09 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 14.78%
- Beta
- 0.88
- R²
- 0.09
- Upside Capture
- 124.28%
- Downside Capture
- 117.52%
Return for Risk
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Hologic, Inc. (HOLX) and compare them to S&P 500 Index.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Hologic, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Hologic, Inc. was 93.75%, occurring on Oct 21, 1999. Recovery took 1478 trading sessions.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
1999 bear market1999 | -93.75%Oct 1999 | 3y 4mo | 5y 10mo | 9y 2moJun 1996 - Sep 2005 |
1993 bear market1993 | -87.62%Dec 1993 | 3y 5mo | 1y 10mo | 5y 3moJul 1990 - Nov 1995 |
Financial crisis2007–2009 | -73.65%Mar 2009 | 1y 2mo | 6y 2mo | 7y 5moDec 2007 - May 2015 |
COVID crash2020 | -46.24%Mar 2020 | 1mo 23d | 2mo 28d | 4mo 21dJan 2020 - Jun 2020 |
2025 selloff2025 | -39.85%May 2025 | 2y 4d | — | 3y 1moMay 2023 - now |
Drawdown Indicators
| HOLX | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | — | -56.78% | — |
Max Drawdown (1Y)Largest decline over 1 year | — | -9.10% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -18.90% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | — | -0.74% | — |
Average DrawdownAverage peak-to-trough decline | — | -10.72% | — |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 1.97% | — |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Hologic, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Hologic, Inc. is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for HOLX, comparing it with other companies in the Medical Instruments & Supplies industry. Currently, HOLX has a P/E ratio of 31.5. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for HOLX relative to other companies in the Medical Instruments & Supplies industry. Currently, HOLX has a P/S ratio of 4.2. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for HOLX in comparison with other companies in the Medical Instruments & Supplies industry. Currently, HOLX has a P/B value of 3.3. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with HOLX
Add Hologic, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with HOLX